Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-03-026479
Filing Date
2003-07-30
Accepted
2003-07-30 17:25:18
Documents
4
Effectiveness Date
2003-07-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ds8.htm S-8 48612
3 OPINION OF DE BRAUW BLACKSTONE WESTBROEK N.V. dex5.htm EX-5 23657
4 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 1431
5 QIAGEN N.V. 1996 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK OPTION PLAN, AS AMENDED dex991.htm EX-99.1 88115
  Complete submission text file 0001193125-03-026479.txt   163679
Mailing Address 28159 AVENUE STANFORD VALENCIA CA 91355
Business Address 5911 KJ VENLO SPOORSTRAAT P7 50 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-107491 | Film No.: 03812410
SIC: 2836 Biological Products, (No Diagnostic Substances)